norcantharidin has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, FG; Du, W; Song, LJ; Sun, LG; Wei, XT; Zhang, R; Zheng, J | 1 |
| Ma, L; Qi, X; Wan, Y; Wang, K; Xie, D; Xie, J; Yang, S | 1 |
2 other study(ies) available for norcantharidin and Glial Cell Tumors
| Article | Year |
|---|---|
Norcantharidin induces growth inhibition and apoptosis of glioma cells by blocking the Raf/MEK/ERK pathway.
Topics: Animals; Apoptosis; Arylamine N-Acetyltransferase; bcl-2-Associated X Protein; Blotting, Western; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Proliferation; Flow Cytometry; Glioma; Humans; MAP Kinase Kinase 1; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Proto-Oncogene Proteins c-bcl-2; raf Kinases; Signal Transduction; Tumor Cells, Cultured | 2014 |
Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; DNA Methylation; Gene Expression Regulation, Neoplastic; Glioma; Humans; Promoter Regions, Genetic; Repressor Proteins; Wnt Signaling Pathway | 2016 |